EFPIA Japan Simulation: Generics Market To Double To ¥2 Trillion By 2022
This article was originally published in PharmAsia News
Executive Summary
In the next 10 years, Japan’s new drugs market will remain fairly flat while the generic drugs market will grow 7% points according to market simulations.